Advanced search
Publication Cover
Gastrointestinal Cancer: Targets and Therapy Volume 8, 2018 - Issue
Journal homepage
284
Views
4
CrossRef citations to date
0
Altmetric
Review

Emerging treatment options for BRAF-mutant colorectal cancer

Carling UrsemDivision of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA, USA
,
Chloe E AtreyaDivision of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA, USA
&
Katherine Van LoonDivision of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA, USACorrespondence[email protected]
Pages 13-23 | Published online: 22 Mar 2018

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jane E. Rogers & Arvind Dasari. (2022) Pharmacotherapy for unresectable metastatic colorectal cancer. Expert Opinion on Pharmacotherapy 23:2, pages 211-220.
Read now
Kyung-Ok Kim, Woo-Jae Park, YunJae Jung & Won-Suk Lee. (2020) Chemotherapeutic effects of MEK kinase inhibitor and BRAF kinase inhibitor on KRAS-mutated human colon cancer cell lines with different microsatellite instability. Journal of Chemotherapy 32:8, pages 437-444.
Read now
Jane E. Rogers & Cathy Eng. (2019) Pharmacotherapeutic considerations for elderly patients with colorectal cancer. Expert Opinion on Pharmacotherapy 20:17, pages 2139-2160.
Read now
Cathy Eng & Jane E. Rogers. (2019) Current synthetic pharmacotherapy for treatment-resistant colorectal cancer: when urgent action is required. Expert Opinion on Pharmacotherapy 20:5, pages 523-534.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.